Binding-Site Purification of Actives (B-SPA) Enables Efficient Large-Scale Progression of Fragment Hits by Combining Multi-Step Array Synthesis With HT Crystallography.
Grosjean H. et al, (2025), Angew Chem Int Ed Engl
Covalent Inhibitors of S100A4 Block the Formation of a Pro-Metastasis Non-Muscle Myosin 2A Complex.
Giroud C. et al, (2024), J Med Chem, 67, 18943 - 18956
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Balıkçı E. et al, (2024), J Med Chem, 67, 7245 - 7259
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.
Xiong Y. et al, (2024), J Med Chem, 67, 5837 - 5853
Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases.
Henderson SH. et al, (2024), Eur J Med Chem, 269
Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.
Raux B. et al, (2024), Bioorg Med Chem Lett, 98
Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements.
Griffen EJ. et al, (2024), Wellcome Open Res, 9
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Boby ML. et al, (2023), Science, 382
Turning high-throughput structural biology into predictive inhibitor design.
Saar KL. et al, (2023), Proc Natl Acad Sci U S A, 120
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.
Londregan AT. et al, (2023), J Med Chem, 66, 460 - 472
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.
Brand M. et al, (2021), J Med Chem
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking.
Schuller M. et al, (2020), bioRxiv
Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors
Boby ML. et al, (2020)
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity.
Schröder M. et al, (2020), J Med Chem, 63, 10224 - 10234
Synthesis and Biological Investigation of (+)-JD1, an Organometallic BET Bromodomain Inhibitor
Hassell-Hart S. et al, (2020), Organometallics, 39, 408 - 416
Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1.
Ni X. et al, (2019), ACS Med Chem Lett, 10, 1661 - 1666
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function.
Fagan V. et al, (2019), J Med Chem, 62, 9008 - 9025
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1).
Xiong Y. et al, (2019), J Med Chem, 62, 8996 - 9007
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
Le Bihan Y-V. et al, (2019), Eur J Med Chem, 177, 316 - 337